Investigation of low density lipoprotein subfractions as a coronary risk factor in normotriglyceridaemic men

Atherosclerosis

Volumn 125, Issue 2, 1996, Pages 231-242

  Rajman, I ^a   Kendall, M J ^a   Cramb, R ^a   Holder, R L ^b   Salih, M ^a   Gammage, M D ^a  

^a QUEEN ELIZABETH HOSPITAL   (United Kingdom)

^b UNIVERSITY OF BIRMINGHAM   (United Kingdom)

Author keywords

Coronary artery disease; LDL subfractions; Triglycerides

Indexed keywords

ACETYLSALICYLIC ACID; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CALCIUM ANTAGONIST; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DIURETIC AGENT; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LOW DENSITY LIPOPROTEIN CHOLESTEROL; NITRATE; TRIACYLGLYCEROL;

ADULT; AGED; ARTICLE; CELL FRACTIONATION; CLINICAL ARTICLE; CONTROLLED STUDY; CORONARY ARTERY DISEASE; CORONARY RISK; HUMAN; HUMAN CELL; HUMAN TISSUE; HYPERTRIGLYCERIDEMIA; MALE; PARTICLE SIZE; PRIORITY JOURNAL; PROTEIN DETERMINATION; RISK FACTOR; SCORING SYSTEM; STATISTICAL ANALYSIS;

EID: 0030572768     PISSN: 00219150     EISSN: None     Source Type: Journal    
DOI: 10.1016/0021-9150(96)05881-9     Document Type: Article

References (25)

1. [1] Krauss RM. Heterogeneity of plasma low-density lipoproteins and atherosclerosis risk. Curr Opin Lipidol 1994;5:339-349.
2. [2] Chapman MJ, Laplaud PM, Luc G, Forgez P, Bruckerte E, Goulinet S, Lagrange D. Further resolution of the low-density lipoprotein spectrum in normal human plasma: Physicochemical characteristics of discrete subspecies separated by density gradient ultracentrifugation. J Lipid Res 1988;29:442-458.
3. [3] Nordestgaard BG, Nielsen LB. Atherosclerosis and arterial influx of lipoproteins. Curr Opin Lipidol 1994;4:252-257.
4. [4] Dejager S, Bruckert E, Chapman MJ. Dense LDL subspecies with diminished oxidative resistance predominate in combined hyperlipidaemia. J Lipid Res 1993;34:295-308.
5. [5] Tribble DL, van der Berg JIM, Motchnik PA, Ames BN, Lewis DM, Chait A, Krauss RM. Oxidative susceptibility of low density lipoprotein subfractions is related to their ubiquinol-10 and alpha-tocopherol content. Proc Natl Acad Sci USA 1994;91:1183-1187.
6. [6] de Graaf J, Hak-Lemmers HLM, Hectors MPL, Demacker PNM, Hendriks JCM, Stalenhoef AFH. Enhanced susceptibility to in vitro oxidation in healthy subjects. Arterioscler Thromb 1991;11:298-306.
7. [7] Hurt-Camejo E, Camejo G, Rosengreen B, Lopez F, Wiklund O, Boujers G. Differential uptake of proteoglycan selected subfractions of LDL by human macrophages. J Lipid Res 1990;31:1387-1398.
8. [8] Rajman I, Maxwell S, Cramb R, Kendall M. Particle size: the key to the atherogenic lipoprotein? Q J Med 1994;87:709-720.
9. [9] Rajman I, Kendall M, Cramb R. The oxidation hypothesis of atherosclerosis. Lancet 1994;344:1363-1364.
10. [10] Campos H, Genest JJ, Blijlevens E, McNamara JR, Jenner JL, Ordovas JM, Wilson PWF, Schaefer EJ. Low density lipoprotein particle size and coronary artery disease. Arterioscler Thromb 1992;12:187-195.
11. [11] Austin MA, Breslow JL, Hennekens CH, Buring JE, Willett WC, Krauss RM. Low-density lipoprotein subclass patterns and risk of myocardial infarction. J Am Med Assoc 1988;26:1917-1921.
12. [12] Coresh J, Kwiterovich PO, Smith HH, Bachorik PS. Association of plasma triglyceride concentration and LDL particle diameter, density and chemical composition with premature coronary artery disease in men and women. J Lipid Res 1993;34:1687-1697.
13. [13] Griffin BA, Freeman DJ, Tait GW, Thomson J, Caslake MJ, Packard CJ, Shepherd J. Role of plasma triglyceride in the regulation of plasma low density lipoprotein (LDL) subfractions: relative contribution of small, dense LDL to coronary heart disease risk. Atherosclerosis 1994;106: 241-253.
14. [14] Austin MA, Hokanson JE, Brunzell JD. Characterization of low-density lipoprotein subclasses: methodologic approaches and clinical relevance. Curr Opin Lipidol 1994;5:395-403.
15. [15] Warnick GR, Benderson JM, Albers JJ. Dextran sulfate-Mg precipitation procedure for quantitation of high-density lipoprotein cholesterol. Clin Chem 1982;28: 1379-1388.
16. [16] Friedewald WT, Levy RI, Fridrickson DS. Estimation of the concentrations of low-density lipoprotein cholesterol in plasma without use of the preparative ultracentrifuge. Clin Chem 1972;18:499-502.
17. [17] Naito HK, Wada M, Erhart LA, Lewis LA. Polycarylamide gel disc electrophoresis as a screening procedure for serum lipoprotein abnormalities. Clin Chem 1973;19:228-234.
18. [18] Muniz N. Measurement of plasma lipoproteins by electrophoresis on polyacrylamide gel. Clin Chem 1977;10:1826-1833.
19. [19] Superko HR, Haskell WL, Krauss RM. Association of lipoprotein subclass distribution with the use of selective and non-selective beta-blocker medications in patients with coronary heart disease. Atherosclerosis 1993;101: 18.
20. [20] Tornwall P, Karpe F, Carlson LA, Hamsten A. Relationship of low density lipoprotein subfractions to angiographically defined coronary artery disease in young survivors of myocardial infarction. Atherosclerosis 1991; 90:67-80.
21. [21] Griffin BA, Packard CJ. Metabolism of VLDL and LDL subclasses. Curr Opin Lipidol 1994;5:200-206.
22. [22] Recommendations of the European Atherosclerosis Society: Prevention of coronary heart disease: scientific background and new clinical guidelines. Nutr Metab Cardiovasc Dis 1992;2:113-156.
23. [23] Austin MA, Krauss RM. Genetic control of low-density-lipoprotein subclasses. Lancet 1986;ii:592.
24. [24] Williams PT, Vranizan KM, Krauss RM. Correlations of plasma lipoproteins with LDL subfractions by particle size in men and women. J Lipid Res 1992;33:765-774.
25. [25] McNamara JR, Campos H, Ordovas JM, Peterson J, Wilson PWF, Schaefer EJ. Effect of gender, age and lipid status on low-density lipoprotein subfraction distribution. Results from the Framingham Offspring Study. Arteriosclerosis 1987;7:483-490.